Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
6.530
-0.010 (-0.15%)
Streaming Delayed Price
Updated: 2:35 PM EDT, May 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine (MindMed) Inc. - Common Shares
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
32
33
Next >
Psychedelic Stock Gainers And Losers From March 2, 2023
March 02, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 01, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
February 28, 2023
Via
Benzinga
MindMed to Participate in March Investor Conferences
February 28, 2023
From
MindMed
Via
Business Wire
Psychedelic Stock Gainers And Losers From February 27, 2023
February 27, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio By 2-To-1 Margin YTD
February 26, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some will bounce back with
Via
Talk Markets
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
February 26, 2023
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage...
Via
Talk Markets
Only 2 Of 5 Cannabis Categories Have Advanced YTD
February 25, 2023
The 5 categories in the cannabis sector perform quite differently from each other but YTD the common trend is mostly downward.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
February 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
February 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
February 22, 2023
Via
Benzinga
Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
February 22, 2023
Gainers
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
February 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
February 20, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin
February 19, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with
Via
Talk Markets
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
February 17, 2023
A look at the performance of the six largest psychedelic stocks by market capitalization.
Via
Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
February 17, 2023
Via
Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
February 16, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
February 15, 2023
Via
Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
February 14, 2023
Via
Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
February 13, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Update
February 12, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. I'm tracking 12 microcap stocks that might bounce back with major returns - dare I say
Via
Talk Markets
Major Psychedelic Compound-Based Stocks UP 13% YTD
February 11, 2023
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances.
Via
Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
February 10, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
February 09, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
February 08, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
February 07, 2023
Via
Benzinga
The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week
February 06, 2023
Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023.
Via
Talk Markets
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
February 06, 2023
Via
Benzinga
The 7 Most Promising Psychedelic Stocks to Buy in February
February 05, 2023
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.
Via
InvestorPlace
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
